Skip to the page

Data / Drug companies / Avobenzone, octinoxate

Avobenzone, octinoxate: 3 companies and 19 products in the FDA NDC directory

Avobenzone, octinoxate is listed in the FDA National Drug Code Directory by 3 companies, with 19 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are lipstick; cream; lotion, and the newest product started marketing on October 25, 2023.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
3
Products
19
Generic (ANDA) products
0 (0.0%)
Application numbers
1
Routes
Topical
Brand names
Boscia Daily Hydration SPF 15 Broad Spectrum For Normal To Oily Skin, GR Lip Butter Cookie SPF 15, Boscia Restorative Day Moisture Broad Spectrum SPF 15 For Dry Skin, GR Lip Butter Ice Mint SPF 15, Boscia Self-Defense Vital Antioxidant Moisture Broad Spectrum SPF 30, GR HD Foundation High Definition SPF 15, Golden Rose Glow Kiss Tinted Lip Balm Peach Shake, Golden Rose Glow Kiss Tinted Lip Balm Berry Pink
openFDA record search
api.fda.gov

Companies that list avobenzone, octinoxate

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Erkul Kozmetik Sanayi Ve Ticaret Anonim Sirketi14lipstick; lotionOver the counter monograph drugsOctober 25, 2023
Boscia LLC3creamOver the counter monograph drugsNovember 16, 2012
Anthony Skin LLC2creamOver the counter monograph drugsJanuary 5, 2020

Dosage forms

Dosage formProductsShare
Lipstick1263.2%
Cream631.6%
Lotion15.3%

Marketing categories

Marketing categoryProductsShare
Over the counter monograph drugs19100%

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.